
Currently out of the existing stock ratings of Peter Verdult, 18 are a BUY (64.29%), 7 are a HOLD (25%), 3 are a SELL (10.71%).
Analyst Peter Verdult, currently employed at CITI, has had 37.5% of price targets met with an average potential upside of 10.87%, reached in 123 days on average. Previously, Peter Verdult worked at BARCLAYS.
Peter Verdult has documented 48 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on SNY, Sanofi ADR at 23-Apr-2026.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) on 8/13/2025. The price target of $54 was fulfilled within 9 days with a profit of $6.06 (12.64%), with a performance score of 14.05.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 16-Oct-2020
$33
$5.27 (19.00%)
$32
8 months 22 days ago
(25-Feb-2026)
17/19 (89.47%)
$-1.02 (-3.00%)
59
Hold Since 09-Sep-2024
$40
$24
1 years 26 days ago
(21-Oct-2025)
1/2 (50%)
$8.57 (27.27%)
127
Hold Since 07-Mar-2024
$22
$31
1 years 9 months 2 days ago
(14-Feb-2025)
3/6 (50%)
$-3.44 (-13.52%)
376
Hold Since 19-Jan-2021
$125
1 years 9 months 24 days ago
(23-Jan-2025)
1/2 (50%)
$17.27 (16.03%)
63
Hold Since 14-Oct-2022
1 years 9 months 24 days ago
(23-Jan-2025)
2/6 (33.33%)
$2.78 (6.01%)
28
What Year was the first public recommendation made by Peter Verdult?